Related Experiment Videos
Clinical inquiries. What is the most effective beta-blocker for heart failure?
Jon O Neher1, Sarah Safranek, Fred Grover
1Valley Medical Center, Family Practice Residency, Renton, WA, USA.
The Journal of Family Practice
|May 10, 2003
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Does vaginal estrogen use increase the risk for adverse cardiovascular outcomes?
The Journal of family practice·2023
How does gender-affirming hormone therapy affect QOL in transgender patients?
The Journal of family practice·2023
How accurate is transcutaneous bilirubin testing in newborns with darker skin tones?
The Journal of family practice·2022
Does an early COPD diagnosis improve long-term outcomes?
The Journal of family practice·2022
Does adjunctive oxytocin infusion during balloon cervical ripening improve labor induction?
The Journal of family practice·2022
Does taking BP medicine at night (vs morning) result in fewer cardiovascular events?
The Journal of family practice·2023
Preventing RSV in children and adults: A vaccine update.
The Journal of family practice·2023
Essential oils: How safe? How effective?
The Journal of family practice·2023
51-year-old woman • History of Graves disease • General fatigue, palpitations, and hand tremors • Dx?
The Journal of family practice·2023
Is low-molecular-weight heparin superior to aspirin for VTE prophylaxis?
The Journal of family practice·2023
Endothelin Receptor Antagonists in Resistant Hypertension and Proteinuric Kidney Disease: Receptor Strategy and Volume Management.
Journal of clinical hypertension (Greenwich, Conn.)·2026
Outcomes After Lymphatic Embolization for Protein-Losing Enteropathy in Congenital Heart Disease.
Journal of the American College of Cardiology·2026
Diagnostic Performance of Reticulocyte Hemoglobin Content (CHr) for Iron Deficiency in Chronic Kidney Disease: A Reanalysis of a Published South African Dataset.
International journal of laboratory hematology·2026
A Review of the Clinical Utility of Tubule-Specific Biomarkers in Sickle Cell Nephropathy.
BioMed research international·2026